Results of Removal of Amalgam Fillings (B. Windham, Editor), 2018,- DAMS Intl. 651-644-4572
1. For the week following amalgam removal, body mercury levels increase significantly, depending on protective measures taken, but within 2 weeks levels fall significantly. (82,89) Chronic conditions can worsen temporarily, but usually improve if adequate precautions are taken to reduce exposure during removal.
2. Removal of amalgam fillings resulted in a significant reduction in body burden and body waste product load of mercury (75,82,88,89,93,95,115,303). Total reduction in mercury levels in blood and urine is often over 80% within a few months (79,82,89,93,115,57). On average those with 29 amalgam surfaces excreted over 3 times more mercury in urine after DMPS challenge than those with 3 amalgam surfaces, and those with 45 amalgam surfaces more than 6 times as much mercury(12b). Those found to be most reactive to metals by immune reactivity test(80) usually reported no more of the common mercury-caused symptoms than those who had lesser levels of metals reactivity but some had more serious effects (95), and those with lesser reactivity were at least as likely to report as those with the most reactivity. And the reported that most of the symptoms were gone or significantly improved after metals replacement (95,14,20,21,22, etc.) Proper safe removal techniques with immune support and sometimes detoxification is needed for best results- this often does not occur as many practitioners have not had special training in such (95,20,21).
3. A study was designed to investigate whether removal of all amalgam fillings was associated with long-term changes in health complaints in a group of patients who attributed subjective health complaints to amalgam fillings (10). Patients previously examined at the Norwegian Dental Biomaterials Adverse Reaction Unit were included in the study and assigned to a treatment group (n = 20) and a reference group (n = 20). Participants in the treatment group had all amalgam fillings replaced with other restorative materials. Follow-ups took place 3 months, 1 and 3 years after removal of all amalgam fillings. There was no intervention in the reference group. In the treatment group, intra-oral and general health complaints were significantly reduced 3 years after completed replacement of amalgam fillings. Reductions in subjective health complaints after replacement of amalgam fillings have also been found in previous studies (11). The reference group received no intervention, and no improvement in health complaints was found. The finding of reduced levels of mercury in serum and urine in this study after amalgam replacement is in agreement with data from several studies showing that replacement of amalgam fillings leads to reduced levels of mercury in blood, plasma and urine (. Previous studies have established that people with amalgam fillings have higher concentrations of mercury in blood, plasma, urine and body organs than people without amalgam fillings (16)
As seen previously in discussion of study(95), those with a lesser number of amalgam fillings were as likely to report as those with the highest number of amalgam fillings. Susceptibility and detoxification capability are known to be important factors in how much one is affected by mercury exposure.
A larger review study of health effects after amalgam removal (17) found similar results as this study, but also focused on the types of chronic conditions from which people recover after amalgam replacement.
4. For the following case studies of amalgam replacement, some clinics primarily replaced amalgam fillings using patient protective measures and supportive supplements, whereas some clinics do something comparable to Hal Huggins total dental revision where in addition to amalgam replacement, patients gold or nickel crowns over amalgam are replaced by biocompatible alternatives, root canals extracted and cavitations checked for and cleaned. There are extensive (many thousands) where removal of amalgam fillings led to cure or significant improvement of serious health problems such as:
periodontal diseases (tissue inflammation, metal mouth, mouth sores, bone loss, burning mouth, etc.) (8,14,21,25,35,40,45,46,57,60,62,75,78,82,94,95,100,115,133,192bcf,212abc,222,233abcdefgh,271,303,313,317,321,322,341,376,525,532,538,551,552,583), oral lichen planus/leukaplakia (14,21,56,86,87,90,101,168, 313a) (oral keratosis (pre cancer)(87,251), immune system/ autoimmune problems (8,14,21,31,35,45,60,62,95,222,270,271,303,313,323,322,342,369,91,212,229,291, 452,470,485, 523,532, 552,581,582), epilepsy (5,35,309,229,386e,557), multiple chemical sensitivities (14,26,35,60,62,95,222,229,232,233,115,303,313,321,342,440,537,583), allergies (8,14,26,35,40,46,62,94,95,97,165, 212,222,228,229,233,271,303,317,322,349,376,440,469, 525c,532,557,581,582,583), asthma (8,14,75,97,222,228,271,322,552,556,557), chronic headaches/migraines (5,8,14,21,25,34,3547f,57,62,95, 185,212abc,222,229, 233abdefgh,271,317,322,349,354,115,376,440,453, 523,525,532,537,538,552,556,582,583), concentration/ADD (14,25,95,233bc,etc.) tachycardia and heart problems (8,14,25,35,59,94,115,205,212,222 , 232,233bcdg, 271,306,310,322,525c, 554,556,557), blood conditions (8,212,222,232,233,271,322,523,551,35,95), Crohn’s disease (14,60,222,229,469,485,594), stomach (gastrointestinal) problems (8,14,21,35,57,62,95,212abc,222,228,229,233bcdg,271,303,317,322,440,469,525c, 532,552), SLE/ lupus (12,31,35,45,60,113,222,233,323,537), dizzyness/vertigo (8,14,40,95,212abc,222,229,233bcdgh,271,322,321,376,453, 525c,551,552), joint pain/arthritis (8,14,21,35,45,62,95,103,212abc,222,229, 233abcg,271,303,313, 322,358,386de,469,523,525c,538,551,552, 556,557,582,583),neuropathy/paresthesia(8,14,35,62,94,163,212,222,303,322,404,556,557), MS(14,25,28,62,94,95,102, 163,170,212,222,229,237,271,291,302,303,322,369,469,485,34,35,229,523,532), ALS(30,28,97,246,423,405,469,470,485,535,35),Alzheimer’s(62,204,251c,303,386e,535,35), Parkinson’s/ muscle tremor (14,222,248,228a,229,233f, 271,322, 469,535,557,212,62,94,98,35), ChronicFatigue Syndrome (CFS) (8,14,27,35,47f, 57,60, 62,88,95,185,212abc,293,229,222,232,236, 237,233abcdfgh, 271,303,313,317, 321,322,323,342,346,369,375,376,386de,440,469,470,523, 532,537,538,551,552, 556,557,558,582), memory disorders (8,14,20,25,27,35,57,94,95,212,222,303,322,440,453,552,557), Sjogren’s Syndrome(45), muscular/jointpain/Fibromyalgia (5,8,14,25,35,60,62,95,185,222,233bcfg,236,237,293,303,317,321,322,346,369,440,469,470,523,527,532,538,552,556,582,94), infertility(9,35,38,229,303,367), endometriosis(229,35,38,9), autism & Asperger’s Syndrome (558,601,602,603), atopic dermatitis(32), (schizophrenia (294,34,35,60), poor concentration/irritability (14,95, etc.) depression(14,25,27,57,62,94,95,107,163,185,212,222,229,233bcfh,237, 271,294,285e,303,317, 321,322,376,386de, 404,453,465,485,523,525c,532,538,551,552,556,557,583,35, 40), insomnia (14,35,62,94,95,212,222,233ag,271,303,317,321,322,376,440,525c, 582,583), nausea(525c), anger(212,233,102,321,557,35,62), anxiety & mental confusion (14,25,62,94,95,212,222,229,233abcfgh,271,303,317, 321,322,440,453,525c, 532,551,557,583,35,57), susceptibility to infections (35,40,62,222,233cd,251,303,317,322,349,350, 469,470,532), antibiotic resistant infection(251,303), cancer (breast, etc./leukemia) (35,38,94,180, 228a,303,469,486,530), alopecia/hair loss (40,187,271,317,322,349,583), sinus problems (14,35,40,47f,94,95,222,271,322,532,583), ringing ears/tinnitus (8,14,35,57,62,94,222,233bcdg,271,303,322,349,376,525c), chronic eye conditions: inflamation/ iritis/ astigmatism/myopia /cataracts/macula degeneration/retinitis pigmentosa, color vision loss, etc. (14,35,95,222,233abcg,271,303,322,440,529), vision disturbances (8,14,35,62,212,233abcg,271,303,322,525c), eczema and psoriasis(31,62,168b,212b,233c,322,323,385, 375, 408, 459,525c,557), hypothyroid & autoimmune thyroiditis (303,369,382,91), skin conditions (8,14,28,32,62,95,212,222,233bc,322,525c,583), urinary/prostrate problems(212,222), hearing loss(102,322,35), Candida(26,35,303,404,537, etc.), PMS(35,6,322, etc.), diabetes(35,369,598, etc.), HIV/AIDs, (485b,35), etc.
The above over 60,000 cases of cure
or significant improvements were not isolated cases of cures; the clinical
studies indicated a large majority of most such type cases treated showed
significant improvement. Chronic health effects are the result of additive and
synergistic effects of all toxic substances one is exposed to along with
synergistic effects with other pathogens, and synergistic
effects of toxic metals and other toxics are often much more
significant than individual effects Details are available and case
histories. For example, one of the clinics(95)
replacing amalgams in a large number of patients with chronic conditions had
full recovery or significant improvement:
in over 90% of cases for: metallic taste, tender teeth, bad breath, and mouth sores;
in over 80% of cases for: depression, irrational fear, headaches/migraines, irritability, dizziness, insomnia, bleeding gums, throat irritation, nasal congestion or discharge, muscle tremor, and leg cramps;
in over 70% of cases for: bloating or intestinal cramps, skin reactions, sciatic pain, chest pain, poor memory, urinary disorders, fatigue, poor concentration/ADD, watery eyes;
in over 60% of cases for: allergies, constipation, muscle fatigue, cold hands/feet, heart problems.
A Jerome meter was used to measure mercury vapor level in the mouth, and the average was 54.6 micrograms mercury per cubic meter of air, far above the Government health guideline for mercury (217).
Some of the above cases used chemical or natural chelation to reduce accumulated mercury body burden in addition to amalgam replacement. Some clinics using DMPS for chelation reported over 80% with chronic health problems were cured or significantly improved (222,271,359).
Other clinics reported similar success. But the recovery rate of those using dentists with special equipment and training in protecting the patient reported much higher success rates than those with standard training and equipment, 97% versus 37 to 88%(435). The Huggins TDR protocol includes testing teeth with metal for level of galvanic current caused by the mixed metals, and removal of the teeth with highest negative galvanic current first (35,228a). This has been found to improve recovery rate for chronic conditions like epilepsy and autoimmune conditions. Metals are being pushed into the body from negatively charged metal dental work with saliva as electrolyte and the highest charged teeth lose the most metal to the body (35).
Clinical studies have found that patch testing is not a good predictor of success of amalgam removal, as a high percentage of those testing negative also recovered from chronic conditions after replacement of fillings (86,87,168, etc.).
The Huggins Clinic using TDR has successfully treated over a thousand patients with chronic autoimmune conditions like MS, Lupus, ALS, AD, diabetes, etc. (35), including himself with the population of over 600(approx. 85%) who experienced significant improvement in MS. In a large German study of MS patients after amalgam revision, extraction resulted in 85% recovery rate versus only 16% for filling replacement alone (222,302). Other cases have found that recovery from serious autoimmune diseases, dementia, or cancer may require more aggressive mercury removal techniques than simple filling replacement due to body burden. This appears to be due to migration of mercury into roots & gums that is not eliminated by simple filling replacement. That such mercury (and similarly bacteria) in the teeth and gums have direct routes to the brain and CNS has been documented by several medical studies (34,325, etc.).
Among those with chronic immune system problems with related immune antibodies, the types showing the highest level of antibody reductions after amalgam removal include glomerular basal membrane, thyroglobulin, and microsomal thyroid antigens(91). TDR and other measures used in metals detox have been found to increase T-cells and immune function in AIDS patients(35).
Swedish researchers have developed a sophisticated test for immune/autoimmune reactions that has proved successful in diagnosing and treating environmentally caused diseases such as lichen planus, CFS,MS, etc. related to mercury and other immunotoxics(60,313,etc.).
Interviews of a large population of Swedish patients that had amalgams removed due to health problems found that virtually all reported significant health improvements and that the health improvements were permanent(233). (study period 17 years) A compilation of an even larger population found similar results(212,282). For example 89% of those reporting allergies had significant improvements or total elimination; extrapolated to U.S.population this would represent over 17 million people who would benefit regarding allergies alone.
VII. Tests for Mercury Level or
Toxicity and Treatment
1. Feces is the major path of excretion of mercury from the body, having a higher correlation to systemic body burden than urine or blood, which tend to correlate with recent exposure level (6b,21abd,35,36,79,80,183,278). For this reason, many researchers consider feces to be the most reliable indicator of daily exposure level to mercury or other toxics. The average level of mercury in feces of populations with amalgam fillings is as much as 1 ppm and approx. 10 times that of a similar group without fillings (79,80,83,335,386,528,25), with significant numbers of those with several filings having over 10 ppm and 170 times those without fillings (80). For those with several fillings daily fecal mercury excretion levels range between 20 to 200 ug/day. The saliva test is another good test for daily mercury exposure, done commonly in Europe and representing one of the largest sources of mercury exposure. There is only a weak correlation between blood or urine mercury levels and body burden or level in a target organ (36,157,183,258,278,11,21abd,6b). Mercury vapor passes through the blood rapidly (half-life in blood is 10 seconds(370)) and accumulates in other parts of the body such as the brain, kidneys, liver, thyroid gland, pituitary gland, etc. Thus, blood test measures mostly recent exposure. Kidneys have a lot of hydroxyl(SH) groups which mercury binds to causing accumulation in the kidneys, and inhibiting excretion(503). As damage occurs to kidneys over time, mercury is less efficiently eliminated (11,36,57,183,216,258,260,503), so urine tests are not reliable for body burden after long term exposure. Some researchers suggest hair offers a better indicator of mercury body burden than blood or urine(279,21ab), though still not totally reliable and may be a better indicator for organic mercury than inorganic. In the early stages of mercury exposure before major systemic damage other than slight fatigue results you usually see high hemoglobin, hemocrit, alkaline phosphatase, and lactic dehydroganese; in later states you usually see marginal hemoglobin, hemocrit, plus low oxyhemoglobin(35). Hair was found to be significantly correlated with fish consumption, as well as with occupational dental exposure and to be a good medium for monitoring internal mercury exposure, except that external occupational exposure can also affect hair levels. Mercury hair level in a population sampled in Madrid Spain ranged from 1.3 to 92.5 ppm. This study found a significant positive correlation between maternal hair mercury and mercury level in nursing infants. Hair mercury levels did not have a significant correlation with urine mercury in one study (340) and did not have a significant correlation to number of fillings (350). One researcher suggests that mercury levels in hair of greater than 5 ppm are indicative of mercury intoxication.
A new test approved by the FDA for diagnosing damage that has been caused by toxic metals like mercury is the (260,35), that measures amount of damage as well as likely source. Mercury blocks enzymes needed to convert some types of porphyrins to hemoglobin and adenosine tri phosphate (ATP). The pattern of which porphyrins are high gives an indication of likely toxic exposure, with high precoproporphyrin almost always high with mercury toxicity, and often coproporphyrin. Another new test combination that is very useful is the Quicksilver Scientific . For testing, see test facilities (80).
Provocation challenge tests after use of chemical chelators such as DMPS or DMSA also are effective at measuring body burden (57,58), but high levels of DMPS can be dangerous to some people- especially those still having amalgam fillings or those allergic to sulfur drugs or sulfites. Many studies using chemical chelators such as DMPS or DMSA have found post chelation levels to be poorly correlated with pre-chelation blood or urine levels (57,115,303), but one study (340) found a significant correlation between pre and post chelation values when using DMPS. Challenge tests using DMPS or DMSA appear to have a better correlation with body burden and toxicity symptoms such as concentration, memory, and motor deficits (290)- with many studies finding a significant correlation between post chelation mercury level and the number of amalgam surfaces (57,172,173,222,290,292,273,303). On average those with 29 amalgam surfaces excreted over 3 times more mercury in urine after DMPS challenge than those with 3 amalgam surfaces, and those with 45 amalgam surfaces more than 6 times as much mercury(12b). Several doctors use 16 ug/L as the upper bound for mercury after DMPS challenge, and consider anyone with higher levels to have excess body burden (222,352). However, one study (290) found significant effects at lower levels. Some researchers believe DMSA has less adverse side effects than DMPS and prefer to use DMSA for chelation for this reason. Some studies have also found DMSA as more effective at removing mercury from the brain (58). A common protocol for DMSA(developed to avoid redistribution effects) is 50 mg orally every 4 hours for 3 days and then off 11 days.
Another chelator used for clogged arteries, EDTA, forms toxic compounds with mercury and can damage brain function (307). Use of EDTA may need to be restricted in those with high Hg levels. N-acetylcysteine (NAC) has been found to be effective at increasing cellular glutathione levels and chelating mercury (54). Experienced doctors have also found additional zinc to be useful when chelating mercury (222) as well as counteracting mercury’s oxidative damage (43). Zinc induces metallothionein which protects against oxidative damage and increases protective enzyme activities and glutathione which tend to inhibit lipid peroxidation and suppress mercury toxicity (430,464). Also, lipoic acid, LA, has been found to dramatically increase excretion of inorganic mercury (over 12-fold), but to cause decreased excretion of organic mercury(572d) and copper. Lipoic acid has a protective effect regarding lead or inorganic mercury toxicity through its antioxidant properties (572), but should not be used with high copper. Lipoicacid and N-acetylcysteine (NAC) also increase glutathione levels and protect against superoxide radical/peroxynitrite damage, so thus have an additional neuroprotective effect (494a,521,524,572c,54,56). Zinc is a mercury and copper antagonist and can be used to lower copper levels and protect against mercury damage. Lipoic acid has been found to have protective effects against cerebral ischemic-reperfusion, excitotoxic amino acid(glutamate) brain injury, mitochondrial dysfunction, diabetic neuropathy (572). Other antioxidants such as carnosine(495a), Coenzyme Q10, Vitamins C & E, gingko biloba, pycnogenol and selenium have also been found protective against degenerative neurological conditions (494,495e, 444,237).
2. Tests suggested by Huggins/Levy (35) for evaluation and treatment of mercury toxicity:
(a) hair element test (386) low hair mercury level does not indicate low body level)(more than 3 essential minerals out of normal range indicates likely metals toxicity)
(b) CBC blood test with differential and platelet count
© blood serum profile
(d) (for person with average exposure with amalgam fillings, average mercury level is 3 to 4 ppm;
lower test level than this likely means person is poor excreter and accumulating mercury, often mercury toxic(35)
(e (note test results sensitive to light, temperature, shaking)
(f) individual tooth electric currents with micro amp meter (replace high negative current teeth first)
(g) patient questionnaire on exposure and symptom history
(h) specific gravity of urine (test for pituitary function, s.g>1.022 normal; s.g.< 1.008 consistent with depression and suicidal tendencies (35)}
3. Note: during initial exposure to mercury the body marshals immune system and other measures to try to deal with the challenge, so many test indicators will be high; after prolonged exposure the body and immune system inevitably lose the battle and measures to combat the challenge decrease- so some test indicator scores decline. Chronic conditions are common during this phase. Also high mercury exposures with low hair mercury or urine mercury level usually indicates body is retaining mercury and likely toxicity problem(35). In such cases where (calcium> 1100 or < 300 ppm) and low, test mercury, manganese, zinc, potassium; mercury toxicity likely and hard to treat since retaining mercury.
Test results indicating mercury/metals toxicity (35):
(a) white blood cell count >7500 or < 4500; (b) hemocrit > 50% or < 40%
© lymphocyte count > 2800 or < 1800; (d) blood protein level > 7.5 gm/100 ml
(e) triglycerides > 150 mg %ml; (f) BUN > 18 or < 12
(g) hair mercury > 1.5 ppm or < .4 ppm; (h) oxyhemoglobin level < 55% saturated
(I) carboxyhemoglubin > 2.5% saturated; (j) T lymphocyte count < 2000; (k) DNA damage/cancer
(l) TSH > 1 ug; (m) hair aluminum > 10 ppm; (n) hair nickel > 1.5 ppm
(o) hair manganese > 0.3 ppm; (p) immune reactive to mercury, nickel, aluminum, etc.
(q) high hemoglobin and hemocrit and high alkaline phosphatase (alk phos) and lactic dehydrogenese(LDA) during initial phases of exposure; with low/marginal hemoglobin and hemocrit plus low oxyhemoglobin during long term chronic fatigue phase.
4. Huggins Total Dental Revision Protoco l(35) or IAOMT
(a) history questionnaire and panel of tests.
(b) replace amalgam fillings starting with filling with highest negative current or highest negative quadrant, with supportive vitamin/mineral supplements.
© extract all root canaled teeth using proper finish protocol.
(d) test and treat cavitations and amalgam tattoos where relevant
(e) supportive supplementation, periodic monitoring tests, evaluate need for further treatment (not usually needed).
(f) avoid acute exposures/challenge to the immune system on a weekly 7/14/21 day pattern.
note: after treatment of many cases of chronic autoimmune conditions such as MS, ALS, Parkinson’s, Alzheimer’s, CFS, Lupus, Rheumatoid Arthritis, etc., it has been observed that often mercury along with root canal toxicity or cavitation toxicity are major factors in these conditions, and most with these conditions improve after TDR if protocol is followed carefully (35,27). Also, it is documented that the process is inflammatory involving free radical/reactive oxygen species effects, and antioxidants have been found to have benefits in treatment (514). Other measures in addition to TDR that have been found to help in treatment of MS in clinical experience are avoidance of milk products, get lots of sunlight, supplementation of calcium AEP (448) and alpha lipoic acid (572). Progesterone creme has been found to promote regrowth of myelin sheaths in animals(448c).
(5) D.Klinghardt (MD), “Migraines, Seizures, and Mercury Toxicity”, Future Medicine Publishing, 1997.; & Klinghardt D; A series of fibromyalgia cases treated for heavy metal toxicity: case report and hypothesis; Journal of Orthopaedic Medicine 2001 23 58-59
(6) R.T McNerney et al, "Mercury Contamination in the Dental Office: A Review", NYS Dental Journal, Nov 1979, p457-458.
(8) Redhe,O. Sick From Amalgam R-Dental Ab, Frejavagen 33, S-79133 Falun, Sweden(100 cases).Olle Redhe ; [firstname.lastname@example.org] ; & Eriksson, L. Amalgam, hälsa och pengar. (Amalgam, health and money) Falktext, Växjö 2000.(98 patients); & G. Eriksson, Torsås. Amalgamsanering - kliniskaresultat efter tre år. (Amalgam removal - clinical results after three years, 2018
(9) “Heavy Metals and Fertility”, J of Toxicology and Environmental Health,Part A, 54:593-611, 1998, I. Gerhard et al, &
Dr.I.Gerhard, Dr. E.Roller, et al, Tubingen Univ. Gynecological Clinic, Heidelberg,1996;
(10) Changes in health complaints after removal of amalgam fillings, Sjursen TT, Lygre GB et al; . 2011 Nov; 38(11): 835–848.
(11) A 7-year prospective quasi-experimental study of the effects of removing dental amalgam in 76 self-referred patients compared with 146 controls. J Psychosom Res. 2004, 57: 103�111. Nerdrum P, Malt UF, et al. (comment in: J Psychosom Res. 2005;59: 189�190; author reply 191�----192) ; & Melchart D, Vogt S, et al. Treatment of health complaints attributed to amalgam. J Dent Res. 2008;87: 349�353. 
(12) Dimaval Scientific monograph, sixth Ed., Jan 1997, Dr Johann Ruprecht, Heyl Corporation. (over 3000 cases)
(14) ON HEALTH, Mats Hanson, 5821 cases, & , Swedish Dept. of Health, 2003, SOU 2003:53, Appendix 10. (800 patients) & . Tf-bladet 1, 1986, Estimate of health status after amalgam removal. Changes in 62 symptoms, reported 3319 times in 519 patients; (Bulletin of the Association of Swedish Dental Mercury Patients) 519 patients (over 80 % significantly improved)
(15) Molin M, Bergman B, Marklund SL, Schutz A, Skerfving S. Mercury, selenium, and glutathione peroxidase before and after amalgam removal in man. Acta Odontol Scand. 1990;48: 189-202. [PubMed]; & Sandborgh-Englund G, Elinder CG, Langworth S, Schutz A, Ekstrand J. Mercury in biological fluids after amalgam removal. J Dent Res. 1998;77: 615-624. [PubMed]; &
Halbach S, Vogt S, Kohler W, Felgenhauer N, Welzl G, Kremers L, et al. Blood and urine mercury levels in adult amalgam patients of a randomized controlled trial: interaction of Hg species in erythrocytes. Environ Res. 2008;107: 69�78. [PubMed]
(16) Correlation between amalgam restorations and mercury concentrations in urine. J Dent Res. Olstad ML, Holland RI, Wandel N, Pettersen AH. 1987; 66: 1179-1182. [PubMed]; & International Programme on Chemical Safety. Environmental health criteria 118. Inorganic mercury. Geneva: World Health Organization; 1991; & Lygre GB, Gr�nnings�ter AG, Gjerdet NR. Kvikks�lv og amalgamfyllinger [Mercury and dental amalgam fillings] Tidsskr Nor Laegeforen. 1998;118:1698-1701. [PubMed]; & Langworth S, Bjorkman L, Elinder CG, J�rup L, Savlin P. Multidisciplinary examination of patients with illness attributed to dental fillings. J Oral Rehabil. 2002;29:705�713. [PubMed]; & Bj�rkman L, Lundekvam BF, L�greid T, Bertelsen BI, Morild I, Lilleng P, et al. Mercury in human brain, blood, muscle and toenails in relation to exposure: an autopsy study. Environ Health. 2007;6:30. [PMC free article] [PubMed]; & Nylander M, Friberg L, Lind B. Mercury concentrations in the human brain and kidneys in relation to exposure from dental amalgam fillings. Swed Dent J. 1987;11:179�187. [PubMed]
(17) Health Effects After Dental Amalgam Removal; Robert L. Siblerud, http://www.orthomolecular.org/library/jom/1990/pdf/1990-v05n02-p095.pdf
(20) International Academy of Oral Medicine and Toxicology (); , & , 2019
(21) Dr. John Murphy, Dublin, & , & , Holistic Dentistry, & .
(22) SUPPLEMENTATION DURING AND AFTER AMALGAM REPLACEMENT, (Excerpt from Dental Mercury Detox by Sam Ziff, Michael Ziff, D.D.S., Mats Hanson, Ph.D.) 2010,
(25) P. Larose. The effect of amalgam removal on 37 health symptoms in humans. Updated 1992 from study reported in Dental Health & Facts 2(1) 1989. Foundation for Toxic-free Dentistry/Bio-Probe, Orlando (80 patients);
(26) “Removal of dental mercury: often an effective treatment for very sensitive patients”, A.F. Zamm, J Orthomolecular Med, 1990, 5(53):138-142. (22 patients)
(27) Mercury toxicity presenting as chronic fatigue, memory impairment and ion: diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994-2006); Wojcik DP, Godfrey ME, et al; 2006 Aug;27(4):415-23. (465 patients)
(28) Having Dental Amalgam Fillings Poses Health Risk, & & & & & &
(30) [Healing of Amyotrophic Lateral Sclerosis: A Case Report]; Mangelsdorf I, Walach H, Mutter J, 2017;24(3):175-181.
(32) Severe dermatitis might be caused by a cross-reaction between nickel and palladium and dental amalgam resolved following removal of dental restorations. Fujii Y, 2017 Apr 12;5(6):795-800.
(34) Patrick Störtebecker, Associate Professor of Neurology, , Stockholm. Mercury Poisoning from Dental amalgam‑ a hazard to the human brain, Bio-Probe, Inc. ISBN: 0-941011001-1
(35) Huggins HA, Levy,TE, Uniformed Consent: the hidden dangers in dental care, 1999, Hampton Roads Publishing Company Inc; & Hal Huggins, Its All in Your Head, 1993; & Center for , 2018, ALS & Depression & other autoimmune conditions (arthritis, diabetes, Lupus, Parkinson’s, Alzheimer’s, Leukemia, etc.)
(36) Sam Queen; Chronic Mercury Toxicity- New Hope Against an Endemic Disease.
(38) Ziff S. and Ziff M. Infertility and Birth Defects: Is Mercury from Dental:Fillings a Hidden Cause?, Bio-Probe, Inc. ISBN: 0-941011-03-8.1987,
(40) F.Perger, Amalgamtherape, in Kompendiu der Regulationspathologie und Therapie,
Sonntag-Verlag, 1990; & K.H.Friese, “Amalgamtherapie fur Arzte und Zahnarzte”, Panta
3, 1992, Haug-Verlag (1200 cases)
(45) Increased frequency of delayed type hypersensitivity to metals in patients with connective tissue disease. Stejskal V, Reynolds T, Bjorklund G. 2015;31:230-6. (SLE,SS,RA)
(46) Veron et al, “Amalgam Dentaires et Allergies”, J Biol Buccale., 1986 : 14; 83‑100 (41 cases); & D.E. Swartzendruber, Med Hyptheses, 1993, v41,n1, p31-34.
(56) Healing of Oral Lichenoid Lesions following Replacement of Dental Amalgam Restorations with Feldspathic Ceramic Inlay-Onlay Restorations: Clinical Results of a Follow-Up Period Varied from Three Months up to Five Years. Karatasli B Mete O, et al; Biomed Res Int. 2018 Dec 3; 2018: 7918781.
& Marxkors, R.: Korrosionserscheinungen an Amalgamf llungen und Deren Auswirkungen auf den Menschlichen Organismus. Das Deutsche Zahn rztebl. 24, 53, 117 and 170, 1970.
(57) M.E.Campbell & M. Godfrey, “Confirmation of Mercury Retention and Toxicity using DMPS provocation”, J of Advancement in Medicine, Vol 7, No.1, Spring 1994; & & M.E.Godfrey,”Chronic ailments related to amalgams”, J.Adv Med, 1990, 3:247-
(60) V.D.M. Stejskal,Dept. Of Clinical Chemistry, Karolinska Institute, Stockholm, Sweden, “Memory Lympocyte IMMUNO‑STIMULATION ASSAY ‑” & VDM Stejskal et al, "MELISA: tool for the study of metal allergy", Toxicology in Vitro, 8(5):991-1000, 1994. http://www.agz-rnk.de/agz/download/3/Mercury_and_Nickel_Allergy.pdf; & Diagnosis and treatment of metal-induced side-effects (allergic and autoimmune illnesses). Stejskal V, Hudecek R, et al; 2006 Dec;27 Suppl 1:7-16.
(62) Dr. J.E. Hardy, Mercury Free: the wisdom behind the growing consumer movement to ban silver dental fillings,
(75)Katsunuma et al, “Anaphylaxis improvement after removal of amalgam fillings”, Annals of Allergy, 1990, 64(5):472-75 & M.Drouet et al, “Is mercury a respiratory tract allergen?”, Allerg Immunol(Paris),1990,22(3):81.
(79) L Bjorkman et al, "Mercury in Saliva and Feces
after Removal of Amalgam Fillings", Toxicology and
Applied Pharmacology, 1997, 144(1), p156-62; & (b) J Dent Res
75: 38-, IADR Abstract 165, 1996.
(80) Test Facilities: Lymphocyte Immune Reactivity Test- ; & Clifford Consulting, Clifford Materials Reactivity Testing,
; & Quicksilver Scientific Tri Test,
& Doctors Data, fecal tests, urine tests, hair tests,
(82) J.Begerow et al,"Long-term mercury excretion in urine after removal of amalgam fillings", Int Arch Occup Health 66:209-212, 1994.
(86) Oral lichenoid lesion related to dental amalgam: A case report. KLAISIRI A, IAMAROON A, et al; J Stomatol Oral Maxillofac Surg. 2019 Jan 18. pii: S2468-7855; &
E.R.Smart et al, "Resolution of lichen planus following removal of amalgam restorations", Br Dent J 178(3): 108-112,1995; & H.Markow, “Regression from orticaria flollowing dental filling removal”,New York State J Med.,1943:1648-1652; & G. Sasaki et al, “Three cases of oral lichenosis caused by metallic dental fillings”, J. Dermatol, Dec 1996, 12:890- 892. (20 cases); & J.Bratel et al, “Effect of Replacement of Dental Amalgam on OLR”, Journal of Dentistry, 1996, 24(1-2):41-45(161 cases).
(87) Amalgam Contact Allergy in Oral Lichenoid Lesions. Thanyavuthi A, Boonchai, et al; Dermatitis. 2016 Jul-Aug;27(4):215-21. & A. Skoglund,Value of epicutaneous patch testing in patients with oral, mucosal lesions of lichenoid character. Scand J Dent Res 102(4): 216-222, 1994; and 99(4):320-9,1991; & P.O. Ostman et al, “Clinical and histologic changes after removal of amalgam”, Oral Surgery, Oral Medicine, & Endodontics, 1996, 81(4):459-465. (103 cases)
(88) M.E.Godfrey, ”Chronic alilments related to amalgams”, J.Adv Med,1990, 3:247
(89)M.Molin et al, "Kinetics of mercury in blood and urine after amalgam removal", J Dent Res 74:420, IADR Abstract 159, 1995.
(90) Role of dental restoration materials in oral mucosal lichenoid lesions. Sharma R, Handa S et al; Indian J Dermatol Venereol Leprol. 2015 Sep-Oct;81(5):478-84.
& P.Koch et al, "Oral lichenoid lesions,mercury hypersensitity, ...",Contact Dermatitis, 33(5):323-328 & S.Freeman et al, “Oral lichenoid lesions caused by allergy to mercury in amalgam”, Contact Dermatitis, 33(6):423-7, Dec 1995 (Denmark) & H. Mobackenet al, Contact Dermatitis, 10:11-15,1984; M.Jolly et al, “Amalgam related chronic ulceration of oral mucosa”, Br Dent J, 1986,160: 434-437.
(91) B. Lindqvist et al, "Effects of removing amalgam fillings from patients with diseases affecting the immune system", Med Sci Res 24(5):355-356,1996; & Ulukapi I. Mercury hypersensitivity from amalgam: report of case. ASDC J Dent Child. 1995 Sep-Oct;62(5):363-4.
(93) L.Barregard et al, "People with high mercury uptake from their own dental amalgam
fillings", Occup Envir Med 52: 124-128, 1995; & S. Langworth et al, A case of
high mercury exposure from dental amalgam”, Eur J Oral Sci, 1996, 104:320-321.
(94) F.Berglund, Case reports spanning 150 years on the adverse effects of dental amalgam, Bio-Probe, Inc., Orlando, Fl, 1995; (245 cured) ISBN 0-9410011-14-3; & F.Berglund, “Thrombocitopeny in 2 children after insertion of amalgam restorations”, Sammanfattningar, Svenska LakarsallskapetsRiksstamma,Nov 1991, 27-29.
(95) "Elimination of symptoms by removal of dental amalgam from mercury poisoned patients", J Orthomol Med 8:145-148, 1993 (120 patients) H.J. Lichtenberg; & “Symptoms before and after proper amalgam removal in relation to serum globulin reaction to metals”, J of Orthomol Med., 1996, 11(4):195-9. (118 cases) http://www.lichtenberg.dk/symptoms_before_and_after_proper.htm
(96) R. Stromberg et al, "A case of unusually high mercury exposure from amalgam fillings", Tandlakartidningen 88(10): 570-572, 1996.
(97) Merritt’s Textbook of Neurology, 9th Ed., Williams and Wilkins, Baltimore, 1995, p668; & O. Redhe et al, "Recovery from ALS after removal of dental amalgam fillings", Int J Risk & Safety in Med 4:229-236, 1994; & N.Vanacore et al, Dirparimento di Scienze Neurologiche, Univer. La Sapienza, Roma, Med Lav (Italy), 1995, Nov, 86(6): 522-533.
(98) A. Seidler et al, "Possible environmental factors for Parkinson's disease", Neurology 46(5):1275-1284,1996; & F.O.Vroom et al, "Mercury vapor intoxication", ?, 95: 305-318,1972; Ohlson et all, “Parkinsons Disease and Occupational Exposure to Mercury”, Scand J. Of Work Environment Health, Vol7, No.4: 252-256, 1981.
(99) M.Nylander et al, Mercury accumulation in tissues from dental staff and controls”, Swedish Dental Journal, 13:235- 243, 1989; & “Mercury in pituitary glands of dentists”, Lancet, Feb 8, 1986.
(100) M.E. Godfrey, "Chronic illness in association with dental amalgam", J Adv Med 3:247-255, 1990; & M.Hanson et al, "The dental amalgam issue: a review", Experientia, 47:9-22,1991.
(101) Association between oral lichenoid reactions and amalgam restorations. Pezeli-Ribaric S, Prpic J et al; 2008 Nov;22(10):1163-7.
& E.Henriksson et al, "Healing of Lichenoid Reactions followin Removal of Amalgam", J Clinical Periodontol, V22,N4, p287-94,1995 & M.Forsbec et al, Journal of Clinical Immunology, 16(1):31-40, Jan 1996.
(102) R.L. Siblerud et al,"Evidence that mercury from silver fillings may be an etiological factor in multiple sclerosis", Sci Total Environ, 1994, 142(3):191-205 , & “Mental health, amalgam fillings, and MS”, Psychol Rep,1992, 70(3 Pt2), 1139-51;& Siblerud R.L. and Kienholz E. Evidence That Mercury From Dental Amalgam May Cause Hearing Loss In Multiple Sclerosis Patients. J. Orthomol. Med, v12#4 pp 240-4 (1997); & R.L.Siblerud, “A commparison of mental health of multiple sclerosis patients with silver dental fillings and those with fillings removed”, Psychol Rep, 1992, 70(3),Pt2, 1139-51. & T.Engalls,Am J Forensic Med Pathol, 4(1):1983, Mar, 55-61.
(103) A.P.Tanchyk,"Amalgam Removal
for Treatment of Arthritis", Gen Dent, v42,n4, July 1994, p354-
(113) T.A.Glavinskiaia et al, “Complexons in the treatment of lupus erghematousus”, Dermatol Venerol, 1980, 12: 24-28; & A.F.Hall, Arch Dermatol 47, 1943, 610-611.
(115)G.Hall, V-TOX, Mercury levels excreted after Vit C IV as chelator‑ by number of fillings
Int Symposium "Status Quo and Perspectives of Amalgam and Other Dental Materials" European Academy, Ostzenhausen/Germany. April 29 ‑ May 1, 1994; & Heavy Metal Bulletin, Apr 1996,Vol.3,Issue 1, p6-8 (200 cured or significantly improved)
(118) L.Tibbling et al, Immunolocial and brain MRI changes in patients with suspected metal intoxication", Int J Occup Med Toxicol 4(2):285-294,1995.
(131) S.Ellermann-Eriksen et al, "Effect of mercuric chloride on macrophage- mediated resistance mechinisms against infection", Toxicology, 93:269-297,1994.
(133) M.Molin et al, "Mercury in plasma in patients allegedly subject to oral galvanism", Scand J Dent Res 95:328-334, 1987.
(148)H.R.Casdorph, Toxic Metal Syndrome, Avery Publishing Group, 1995.
(163) Ahlrot-Westerlund B. Multiple Sclerosis and mercury in cerebrospinal fluid. Second Nordic Symposium on Trace Elements and Human Health, Odense, Denmark, Aug 1987; & Nutrition Research, 1985 Supplement; &
Monica Kauppi and Dr Britt Ahlrot-Westerlund, Heavy Metal Bulletin 2(3):11-12 December 1995. (Vit B12)
(165) G.Anneroth et al, “Comprehensive Medical Examination of patients with alleged adverse effects from dental amalgams”, Acta Odontal Scand, 1992,50(2):101-11.
(167)R.Brehler et al,”Mercury sensitization in amalgam fillings”, Dtsch med Wochenschr,1993,118(13):451-6.
(168) J.Laine et al, “Resolution of oral lichenoid lesions after replacement of amalgam restorations”, Br J Dermatol, 1992,126(1):10-15; & S.H.Ibbotson et al, “The relevance of amalgam replacement on oral lichenoid reactions”, British Journal of Dermatology, 134(3):420-3, Mar, 1996..
(170) Birgitta Brunes, Adima Bergli, From MS diagnosis to better health ,1996. www.melisa.org; & DAMS, Recoveries from MS after amalgam replacement,
; & Maile Pouls, Townsend Letter, 1999, www.heall.com/healingnews/may/heavy_metals.html
(180) O.F.Pinto et al, J Intl Acad Prev Med, Vol 3, No.2, 1976.
(182) J Pleva, J Orthomol Psych, Vol 12, No.3, 1983; & J. Of Orthomol. Medicine 1989, 4:141- 148. &
“Mercury-A Public Health Hazard”,Reviews on Environmental Health,1994,10:1-27
(187)Klobusch J, Rabe T, Gerhard I, Runnebaum B, "Alopecia and environmental pollution" Klinisches Labor 1992, 38:469‑ 476
(192) L.J. Calsakis et al, "Alergy to Silver Amalgams",Oral Surg,46:371-5,1978
(199)Dr. P.Kraub & M.Deyhle, Universitat Tubingen- Institut fur Organische Chemie,
“Field Study on the Mercury Content of Saliva”, 1997
(200) S.Langworth et al, “A case of high mercury exposurte from dental amalgam”, Eur J Oral Sci 104:320- 321,1996.
(204) Tom Warren, Beating Alzheimer’s, Avery Publishing Group, 1991; &
(205) M.F. Ziff et al, A Persuasive New Look at Heart Disease As It Relates to Mercury, Bio-Probe, Inc.,ISBN 0-941011-08-9; & J. of American College ofCardiology V33,#6, pp1578‑1583, 1999.
(212) (a) Ziff, M.F., “Documented clinical side effects to dental amalgams”, ADV. Dent. Res.,1992; 1(6):131-134; & Ziff, S.,Dentistry without Mercury, 8th Edition, 1996, Bio-Probe, Inc. , ISBN 0-941011-04-6; & Dental Mercury Detox, Bio-Probe, Inc. http://www.bioprobe.com. (Cases: FDA Patient Adverse Reaction Reports-762, Dr.M.Hanson-Swedish patients-519, Dr. H. Lichtenberg-100 Danish patients , Siblerud, RL. Health effects after dental amalgam removal. J. Orthomol. Med. 5, 1990, 95-106(86 patients); & P. Larose. The effect of amalgam removal on 37 health symptoms in humans. Updated 1992 from study reported in Dental Health & Facts 2(1) 1989. Foundation for Toxic-free Dentistry/Bio-Probe, Orlando(80 patients); & Zamm, AV. Removal of dental mercury: often an effective treatment for the very sensitive patient. J Orthomol. Med. 5, 1990, 138-142(22 patients)
(b)Hovmand, O. Oral galvanisme - erfaringer fra praxis. Tandlaegebladet 91, 1987, 473-476.(59 patients)
(& (c)over 1000 additional cases of significant improvement reported directly to FDA)
(222) M. Daunderer, “Improvement of Nerve and Immunological Damages after Amalgam Removal”, Amer. J. Of Probiotic Dentistry and Medicine, Jan 1991. (800 cases, replacement & DMPS); & Max Daunderer, Handbuch der Amalgamvergiftung, Ecomed Verlag, Landsberg 1998, ISBN 3‑609‑71750‑5 (in German) (1100 cases)
(228) Dr. Thomas Rau, Paracelsus Alergy Clinic, Lustmuhle, Switzerland, 1996, The Swiss Secret to Optimal Health: (http://www.pbmn.org/inner/rau_interview.html)
& E. Cutler,Winning the War against Asthma &
(229) M.Davis,editor, Defense Against Mystery Syndromes”, Chek Printing Co.,
March, 1994(case histories documented); & Andrew Hall Cutler, PhD, PE; Amalgam Illness:Diagnosis and Treatment; 1996 , www.noamalgam.com/
(232) Adolph Coors Foundation, “Coors Amalgam Study: Effects of placement and Removal of Amalgam fillings”, 1995. (www) & InternationsDAMS Newsletter,
p17, Vol VII, Issue 2, Spring 1997. (31 cases)
(233) F.Berglund, Bjerner/Helm, Klock,Ripa, Lindforss, Mornstad, Ostlin), “Improved Health after Removal of dental amalgam fillings”, Swedish Assoc. Of Dental Mercury Patients, 1998. (www.tf.nu) ; (a) Lindforss, H, Marqvardsen, O, Olsson, S, Henningsson, M. Effekter på hälsan efter avlägsnandet avamalgamfyllningar (Effects on health after removal of amalgam fillings). Tandläkartidn. 86(4), 1994, 205-211; (503 patients); & (b) Amalgamutbyte - en väg mot bättre hälsa? (Amalgam removal - a road to better health?) Försäkringskassan, Stockholms län, 1991, Östlin, L. (308 patients); & (c) U. Veranderung des allgemeinen Gesundheitszustand nach Amalgamentfernung. (Changes in general health after amalgam removal) GZM, Ganzheitl. Zahnmed. 2(1), 1997, 22-28(253 patients); (78 % imp) &(d) Strömberg, R, Langworth, S. Förbättras hälsan efter borttagningav amalgam? (Does health improve after removal of amalgam?) Tandläkartidn. 90(9), 1998, 23-29(233 patients); & (e)LEK-studien, LandstingetDalarna, Bjerner, B & Hjelm, H. dec. 1991, LEK-studien Dalarna. Sammanställning inför hearing med SoS:s "tungmetallgrupp", 90-11-21(207 patients); &(f) Klock, B, Blomgren, J, Ripa, U, Andrup B. Effekt av amalgamavlägsnande på patienter som misstänker att de lider eller har lidit avamalgamförgiftning. (Effect of amalgam removal in patients who suspect amalgam poisoning) Tandläkartidningen 81, 1989, 1297-1302(198 patients); & (g)Mörnstad H, Teivens A, Wänman A. Sjukdomsbild och attityder till amalgam. En enkätstudie bland medlemmar i Tandvårdsskadeförbundet. (Health status and attitudes to amalgam. A questionnaire to members of the Dental Patient Organization) Tandläkartidningen 86, 1994, 196-204(132 patients) & (h)Sven Langworth et al, Amalgam news and Amalgamkadefonden, 1997 http://iaomt.org/articles/files/files214/Hansen-%20effects%20of%20amal%20removal.pdf
(234) P.E. Bigazzi, “Autoimmunity and Heavy Metals”, Lupus, 1994; 3: 449-453.
(235) H.J.Hamre, Mercury from Dental Amalga and Chronic Fatigue Syndrom”, The CFIDS Chronicle, Fall 1994, p44-47.
(236) Metals as a common trigger of inflammation resulting in
non-specific symptoms: diagnosis and treatment. Stejskal V.
Isr Med Assoc J. 2014 Dec;16(12):753-8. (CFS,FM), & Amalgam Replacement in CFS patients, Neuroendocrinol Lett. 20,1999, 289-98. Stejskal VDM, Danersund A, Danersund A, Lindvall A, Hudecek R, Nordman V, Yaqob A, Mayer W, Bieger W, Lindh U.
(237) Dental Materials and Health, Swedish Dept. of Health, 2003, SOU 2003:53, Appendix 10. ()
(246) K.Iyer et al, “Mercury Poisoning in a dentist”, Arch Neurol,1976, 33:788-790.
251) Y.Omura et al, Heart Disease Research Foundation, NY,NY, “Role of mercury in resistant infections and recovery after Hg detox with cilantro”, Acupuncture & Electro-Theraputics Research, 20(3):195-229, 1995
(252) K.Iyer et al, “Mercury Poisoning in a Dentist”, Arch Neurol, 33:788-90, Nov 1976.
(270) D.W.Eggleston, “Effect of dental amalgam and nickel alloys on T-lympocytes”,J Prosthet Dent. 51(5):617- 623,1984; & D.W.Eggleston et al, J Prosthet Dent, 1987,58(6),704-7; & J of the American Medical Assoc., Sept 96.
(271) B.A.Weber, “The Marburg Amalgam Study”, Arzt und Umwelt, Apr, 1995; (266 cases) & (b) B.A. Weber, “Amalgam and Allergy”, Institute for Naturopathic Medicine, 1994; & © B.A. Weber, “Conuctivitis sicca(dry eye study)”,Institute for Naturopathic Medicine, 1994; & (d) B.A.Weber, “Alternative treatment of Multiple Sclerosis, Tumor, or Cancer”, Institute for Naturopathic Medicine 1997 (40 MS cases),
(282) Press Release, Swedish Council for Planning and Coordinating Research (FRN), Stockholm, 19 February, 1998.
(285) Hua MS, Huang CC, Yang YJ. “Chronic elemental mercury intoxication”, Brain Inj, 1996, 10(5):377-84;
(291) H.A. Huggins, Solving the MS Mystery, 2002; & H.A.Huggins & TE Levy, “cerebrospinal fluid protein changes in MS after Dental amalgam removal”, Alternative Med Rev, Aug 1998, 3(4):295-300.
(293) H.Huggins & Editors of Alternative Medicine Digest, Chronic Fatigue, Fibromyalgia & Environmental Illness, Future Medicine Publishing, Inc, 1998, p197-.
(294) Siblerud R “Do amalgam fillings influence manic depression?”, Journal of Orthomol. Medicine, 1998, www.yourhealthbase.com/amalgams.html
(302) D, Klinghardt, IAOMT Conference & tape, 1998; “large study by M.Daunderer (Germany) of MS patients after amalgam removal”. (over 200 cases)
(303) Heavy Metal and Chemical Toxicity, Dietrich Klinghardt, MD, Ph.D. ;
& Mercury Toxicity and Systemic Elimination Agents, D. Klinghardt & J Mercola(DO), J of Nutritional and Environmental Medicine, 2001, 11:53-62; & Amalgam Detox, Klinghardt Academy of Neurobiology, 2008
(304) Fibromyalgia Syndrome and Heavy Metal Toxicity, Dietrich Klinghardt, MD, Ph.D.
(306) E.M. Oliveira et al, “Mercury effects on the contractile activity of the heart muscle”, Toxicol Appl Pharmacol, 1:86-91,1994.
(309) The Tribune, Mesa, Az., 13 Apr 1998, (Paul Mills, Apalachee Junction); & Kyle BP, Nordic J of Biological Med, 2000.
(310 “The relationship between mercury from dental amalgam and the cardiovascular system”, Science of the Total Envir, 1990, 99(1-2): 23-35) R.L. Siblerud,
(312) Richard Hanson, The Key to Ultimate Health, 1999; & J.Lee (mD), What Your Doctor May Not Tell You About Hormones, DAMS, (800-311-6265)
(313) “Mercury-Specific Lymphocytes: An Indication of Mercury Allergy in Man”, J. Of Clinical Immunology, 1996, Vol16(1): 31-40. (18c), V.D.M. Stejskal et al,
(317) S. Zinecker, “Amalgam: Quecksilberdamfe ...”, der Kassenarzt, 1992, 4:23; “Praxiproblem Amalgam”, Der Allgermeinarzt, 1995,17(11):1215-1221. (1800 patients)
(321) R.L. Siblerud, ”Relationship between dental amalgam and health”, Toxic Substances Journal, 1990b, 10:425-444; & “Effects on health following removal of dental amalgams”, J.Orthomolecular Med., 5(2): 95-106; & “Relationship between amalgam fillings and oral cavity health”, Ann Dent, 1990, 49(2):6-10.
(322) P. Engel, “Beobachtungen uber die gesundheit vor und nach amalgamentfernug”, Schweiz Monatschr Zuhbmed, 1998, vol 108(8). (75 cases) & Suspicious dentist now believes patients" (Puls-Tipp, Issue Nov. 2001) & "Amalgam was guilty" (Puls-Tipp, Issue Nov. 2001) http://www.amalgam-info.ch/html/engel.html & http://www.amalgam-info.ch/awschu-e.pdf
(323) Dr. Kohdera, Faculty of Dentistry, Osaka Univ, Internationsl Congress of Allergology and Clinical Immunology, EAACI, Stockholm, June 1994; & Heavy Metal Bulletin, Vol 1, Issue 2, Oct 1994. (160 cases cured)
(325) C.R. Adams et al, “Hg & ALS”, JAMA, 1983, 250(5):642-5; & M. Su et al, J Neurol Sci, 1998, 156(1):12-7; & B. Arvidson (Sweden), Muscle Nerve, 1992, 15(10);1089-94,
(341) A.Tosti et al, “Contact stomatitis”, Semin Cutan Med Surg, 1997, 16(4):314-9; & T.Nakada et al, “Patch test materials for mercury allergic contact dematitis”, Dermatitis, 1997, 36(5):237-9; & Guttman-Yassky E, Weltfriend S, Bergman R. Resolution of orofacial granulomatosis with amalgam removal. J Eur Acad Dermatol Venereol. 2003 May;17(3):344-7
(346) Clauw DJ, “The pathogenesis of chronic pain and fatigue syndromes: Fibromyalgia” Med Hypothesis, 1995, 44:369-78; & Hanson S, Fibromyalgia, glutamate, and mercury. Heavy Metal Bulletin, Issue 4, 1999, p5,6.; & (c) Remedyfind survey of CFS/FM patients,
(349) M.Schaeffer et al, “Risikofaktor Amalgam-Ein Problemstoff”,Schriftenreihe mweltmedizin, Forum Medizin Verlagsgesellschaft, 1996; & (b)Nixon, DE, Mussmann GV, Moyer TP. Inorganic, organic, and total mercury in blood and urine. J Anal Toxicol, 1996; 10(1): 17-22.
(350) F. Schweinsberg, “Risk estimation of mercury intake from different sources”, Toxicol. Lett. 1994, 72: _45-51; & L.D. Pzheusskaia, “Disintoxication therapy of patients with nonspecific inflammatory diseases of the female genital organs”, Akush. Ginekol 1977, (4): 30-34;
(359) G. Tapparo, :Toxische Untersunchungen zu Amalgam”, Die Zahn Arztwoche, 1992
(367) I. Gerhard, “Amalgam aus gynakologischer Sicht”, Der Frauenarzt, 1995,36(6): 627-28; & “Schdstoffe und Fertillitatsstorungen”,, Schwermetalleund Mineralstoffe, Geburtshilfe Frauenheikd, 1992, 52(7):383-396; & (b) “Reproductive risks of heavy metal and pesticides in women”, in: Reproductive Toxicology, M.Richardson(ed.), VCH Weinhelm, 1993, 167-83; &(c) “Unfruchtbarkeit bei Frauen durch Umwelterkrankungen, JD. Kruse-Jarres(Ed.), 1993, 51-68.
(368) Metal- specific memory lymphoctes: biomarkers of sensitivity in man. Neuroendocrinology Letters, 1999. Stejskal VDM, Danersund A, Lindvall A, Hudecek R, Nordman V, Yaqob A et al.
(369) The beneficial effect of amalgam replacement on health in patients with autoimmunity. Neuro Endocrinol Lett. 2004 Jun;25(3):2118 Prochazkova J, Sterzl I, Kucerova H, Bartova J, Stejskal VD; & Mercury and nickel allergy: risk factors in fatigue and autoimmunity. Neuroendocrinology Letters 1999; 20:221-228. Sterzl I, Prochazkova J, Stejaskal VDM et al,
(375). Metal- specific memory lymphocytes: biomarkers of sensitivity in man. Neuroendocrinology Letters, 1999; 20: 289-98 Stejskal VDM, Danersund A, Lindvall A, Hudecek R, Nordman V, Yaqob A et al. www.melisa.org
(376) Melchart D, Wuhr E, Weidenhammer W, Kremers L. A multicenter survey of amalgam fillings and subjective complaints in non-selected patients in the dental practice. Eur J Oral Sci 1998; 106:770-77 (6,744 patients in 34 clinics) & Treatment of Health Complaints Attributed to Amalgam, J Dent Res 87(4):349-353, 2008, D. Melchart, S. Vogt, W. Köhler, A. Streng, W. Weidenhammer, L. Kremers, R. Hickel, N. Felgenhauer, T. Zilker, E. Wühr, and S. Halbach , (90 patients)
(382) The fatigue syndrome in autoimmune thyroiditis with polyglandular activation of autoimmunity. Vnitrni Lekarstvi 1998; 44: 456-60, Sterzl I, Fucikova T, Zamrazil V; &(b) Sterzl I, Hrda P, Prochazkova J, Bartova J, Reactions to metals in patients with chronicgue and autoimmune endocrinopathy. Vnitr Lek 1999 Sep;45(9):527‑31 ;
(385) Kohdera T, Koh N, Koh R. Antigen-specific lympocyte stimulation test on patients with psoriasis vulgaris. XVI International Congress of Allergology and Clinical Immunology, Oct 1997, Cancoon, Mexico; & Ionescu G. Schwermetallbelastung bei atopischer Dermatitis und Psoriasis. BiolMed 1996; 2:65-68.
(386) Great Plains Laboratory
(404) Candida, Dysbiosis and Amalgam. J. Adv. Med. vol 9 no 2 (1996), M. E. Godfrey; & Immunity to Candida Albicans: Th1,Th2 cells and beyond. Curr Opin Microbiol 1999, 2(4):363-7 Romani L; & Candida Albicans Therapy: Dental mercury removal, an effective adjunct. J. Orthmol. Med. v1#4 pp261-5 (1986), Alfred V. Zamm.
(405) The role of metals in autoimmune diseases and the link to neuroendocrinology Neuroendocrinology Letters, 20:345‑358, 1999; Stejskal J, Stejskal V. www.melisa.org
(408) Exacerbation of pustular psoriasis in mercury poisoning. Hautarzt 1994 Oct;45(10):708‑10. Wehner‑Caroli J; Scherwitz C; Schweinsberg F; Fierlbeck G.
(423) “Mercury intoxication simulating ALS”, JAMA, 1983, 250(5):642-5 C.R. Adams et al; & T.Barber, “Inorganic mercury intoxificationsimilar to ALS”, J of Occup Med, 1978, 20:667-9;
(435) Norwegian Dept. Of Health, “The Use of Dental Restoration Materials in Norway”, Oct 1998, IK-2652, & Press Release, Australian NHMRC, Mar 1999 ; & Heavy Metal Bulletin, Issue 1, 1999.
(440) Kidd RF. Results of dental amalgam removal and mercury detoxification. Alternative Therapies, Health Med, 2000 Jul;6(4):49‑55. & Gary Null,
(453) Blumer W, "Mercury toxicity and dental amalgam fillings", Journal of Advancement in Medicine, v.11, n.3, Fall 1998, p.219.
(459) Isny Clinic (South Germany) Kurt Muller , MD, member of Editorial board for Ganzheitliches Medicine Journal. Wassertornstrasse 6, Isny, BRD fax: 0049 7562 550 52
(469)BrainRecovery.com, the book, by David Perlmutter MD; Perlmutter Health Center, Naples, Florida; &M.M. van Benschoten, ““Acupoint Energetics of Mercury Toxicity and Amalgam Removal with Case Studies,”” American Journal of Acupuncture, Vol. 22, No. 3, 1994, pp. 251-262;
(470) Dr. Garth Nicholson, Institute for Molecular Medicine, Huntington Beach, Calif., www.immed.org & 07‑18‑2001 Mycoplasmas – The Missing Link in Fatiguing Illnesses & New Treatments for Chronic Infections Found in Fibromyalgia Syndrome, Chronic Fatigue Syndrome, Rheumatoid Arthritis, and Gulf War Illnesses;
& Dr. G. Nicholson, Institute for Molecular Medicine, New Treatments for Chronic Infections Found in Fibromyalgia Syndrome, Chronic Fatigue Syndrome, Rheumatoid Arthritis, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Gulf War Illnesses,
(485) Hulda Clark, The Cure for all Diseases, 2000, amalgam replacement, dental revision, detoxification, and treatment for parasites) & (U.S. CDC confirms parasites common in those with chronic immune conditions); & The , 2003,
(486)Hulda Clark, , 1998; & Gerson Clinics, www.gerson.org
& Charlotte Du Bois and John Lubecki, The End of Cancer, Nelson’s Books, 2003; & The Cancer Homepage
(523) CBS Television Network,” 60 Minutes”, television program narrated by Morley Safer, December 12, 1990
(525) The shocking tooth about trigeminal neuralgia. New England Journal of Medicine, Vol. 342, June 29, 2000, p. 2003, Cheshire, William P., Jr. & Potentials of and currents between dental metallic restorations. Scand J Dent Res 1982; 90 :404-8, Bergman M, Ginstrup O, Nilsson B; & Hugoson A. Results obtained from patients referred for the investigation of complaints related to oral galvanism. Swed Dent J 1986;10:15-28;(b) & Muller AW, Van Loon LA, Davidson CL. Electrical potentials of restorations in subjects without oral complaints. J Oral Rehabil 1990;17:419-24; & (c) Raue H., "Resistance to therapy; Think of tooth fillings", Medical Practice, vol. 32, n.72, p.2303- 2309, 6 Sept 1980(over 1000 cases) &(d) Johann Lechner, "Dental Materials and Psychoneuroimmunology Conference". Danderyd Hospital, 14-16 August, 1998;
(535) K. Sullivan, Evidence Implicating Amalgam in Alzheimer’s Disease,
(537) Amalgam replacement with detox using NDF, case histories,
(551) Dr. Harald Hamre (Norwegian physician treating mercury toxicity), Amalgam and Illness, 1998.
Biological Trace Element Research December 2007, Volume 120, , pp 163–170| Removal of dental amalgam and other metal alloys supported by antioxidant therapy alleviates symptoms and improves quality of life in patients with amalgam-associated ill health. 2002; 23(5-6): 459-82. Lindh U, Hudecek R, Danersund A, Eriksson S, Lindvall A.; (796 cases)
(554) Swedish newspaper "Dagens Nyheter" April 26, 2003, "Healthy Enough to Work Again Without Amalgam.”
(556) (a)Aspen Clinic for Preventive and Environ-mental Medicine in Colorado http://curezone.org/testimonials/003.htm ;
& (b), Dr. Lewis Cone, Plano, Texas, ; & ©ICNR Case Study #11
(557) Psychiatric Disturbances and Toxic Metals, Townsend Letter for Doctor's & Patients April 2002; & Alternative & Complementary Therapies (a magazine for doctors), Aug 2002;
(558) HMD Detox Forumula, Testimonials, http://www.detoxmetals.com/index.php?option=com_content&task=section&id=6&Itemid=42
&(b) Mark Breiner, DDS, Whole-Body Dentistry: DiscoverThe Missing Piece To Better Health, ; &
(581) Dr. E. Valentine-Thon, Head-Immunology Department, Laboratory Center, Bremen, Friedrich-Karl-Str.22 28205 Germany; & LTT-MELISA is clinically relevant for detecting and monitoring metal sensitivity. Valentine-Thon E, Muller K, Guzzi, et al; 2006 Dec;27 Suppl 1:17-24.(700 pat)
Neuroendocrinol Lett 27:17-24,2006.
(582) Dagmar Magnusson, Dentist, Samos, Greece, 1000 patients with amalgam replacement with over 80% significantly improved,
(583) Dr. Ronald King, DDS, Patient Experience After Amalgam Replacement, (33)
(594) Mercury and food intolerances: common causes of chronic conditions related to leaky gut and intestinal dysfunction such as ulcerative colitis, IBS, Crohn’s, eczema, psoriasis, food allergies, arthritis, ADHD, and autoimmune disease; and treatments that improve these conditions. http://www.myflcv.com/leakyghg.html
(598) Overcoming Depression, Dr. Russell Blaylock, MD, The Blaylock Wellness Report, Vol 5, No. 3, March 2008, & Food Additives, What you eat can kill you, Vol 4, No. 10, Oct 2007, http://www.blaylockreport.com/
(601) B.Windham, the autism mercury connection: documentation, http://www.myflcv.com/kidshg.html & http://www.myflcv.com/autismc.html & http://www.myflcv.com/autismgc.html & http://www.myflcv.com/ASDendo.html
other references and additional information on all conditions:
(602) Parent Ratings of Behavioral Effects of Biomedical Interventions for large group of parents of children who had autism https://www.autism.com
& Parent Ratings of Behavioral Effects of Biomedical Interventions for Asperger Syndrome http://www.autism.com/treatable/form34qraspergersyndrome.htm
(603) Diagnosis and Treatment of Heavy Metal Toxicity in Autism Spectrum Disorders(ASD), DAN Medical Subcommittee on Autism and Mercury, J Bradstreet, J El-Dahr, A Holmes, S Cave, and B Haley, 2000.